News
Needham Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Lucid Diagnostics, Lowers Price Target to $3
27 Mar 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
27 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Lucid Diagnostics Q4 EPS $(0.23) Beats $(0.26) Estimate, Sales $1.04M Miss $1.05M Estimate
25 Mar 24
Earnings, News
Lucid Diagnostics Provides Business Update; Reports Q4 EsoGuard Revenue Of $1.04M, Up 33% Sequentially
25 Mar 24
Earnings, News
Earnings Scheduled For March 25, 2024
25 Mar 24
Earnings
Earnings Preview: Lucid Diagnostics
22 Mar 24
Earnings
Lucid Diagnostics Announces Data From The First Prospective Clinical Validation Study Of EsoGuard Esophageal Precancer Testing In A Screening Population
21 Mar 24
Biotech, News, General
Lucid Diagnostics Announces Multiple Presentations At Digestive Disease Week 2024 Conference
20 Mar 24
Biotech, News, Events, General
12 Health Care Stocks Moving In Monday's After-Market Session
19 Feb 24
Movers
Press releases
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
8 Apr 24
Press Releases
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
26 Mar 24
Earnings, Press Releases
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
25 Mar 24
Earnings, Press Releases
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
21 Mar 24
Press Releases
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
20 Mar 24
Press Releases
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024
12 Mar 24
Small Cap, Press Releases
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
16 Feb 24
Press Releases
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
15 Feb 24
Press Releases
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
8 Feb 24
News, Contracts, Press Releases